TIZIANA LIFE SCIENCES LTD

Investors eye Tiziana Life Sciences as it heads to the ACTRIMS‑ECTRIMS conference to showcase foralumab’s intranasal breakthrough for MS and Alzheimer’s.

Explore TLSA’s latest trading data, valuation vs. peers, and biopharma growth potential—discover why investors see value below its 200‑day SMA.